How long does Wegovy take to reduce your appetite?

The first two weeks: you might feel it sooner than you expect

Picture this: you've collected your first Wegovy pen, taken your 0.25mg injection, and now you're wondering whether anything is actually happening. Some people are surprised to find that within three to five days food just feels less compelling. Meals that would normally have been finished without a thought get left half-eaten. That's semaglutide beginning to influence GLP-1 receptors in the brain's appetite centres and slowing gastric emptying — signals that reduce how urgently your body calls for food.

Not everyone feels this straight away, and that's equally normal. The 0.25mg starting dose is set at that level specifically to let the body adapt rather than to deliver the full therapeutic effect. Think of it as your system finding its footing. Nausea and other gastrointestinal sensations are most common in these early weeks, and the reduced appetite you feel may be as much about those unsettled feelings as about the medicine's direct effect on hunger. Both settle for most people within the first fortnight. The NHS semaglutide medicines page has a clear breakdown of early side effects and what to expect from them.

If you're curious how quickly semaglutide reduces appetite and what that process typically looks like day by day, our page on that covers the detail alongside a comparison of different formulations, including the oral Wegovy tablet, which you can also find on our page on how long semaglutide takes to suppress appetite.

Weeks four to twelve: appetite suppression deepens with each dose step

This is where most people say the change feels real and lasting rather than occasional. Moving from 0.25mg to 0.5mg at week five (or thereabouts, per your prescriber's guidance) often brings a noticeable step up in how full meals leave you feeling, and how long that fullness lasts. By 1.0mg (reached around week nine) many people describe eating about two-thirds of their previous portion size without actively trying to restrict themselves.

The STEP 1 trial, published in the New England Journal of Medicine, followed adults on semaglutide 2.4mg for 68 weeks and found an average body-weight reduction of around 15%. That outcome is built on the cumulative appetite effect across the full schedule, not a sudden drop at the start. The early weeks lay the groundwork; the middle weeks are where appetite suppression tends to do its most consistent work.

One thing our prescribers hear from patients during this phase: lunch starts to feel like enough when it never used to be. The instinct to graze mid-afternoon fades. Some people describe it as the mental noise around food quietening, fewer intrusive thoughts about what to eat next, rather than a sense of forcing themselves not to eat. That distinction matters.

For more on the pace of those early changes specifically, how quickly Wegovy suppresses appetite looks at week-by-week experience in more detail.

Reaching maintenance dose: what to expect from 2.4mg (and 7.2mg)

Most people reach the 2.4mg maintenance dose around week seventeen of their schedule. At this point, appetite suppression is typically at its most stable and reliable. Hunger cues don't disappear entirely (and they shouldn't) but the intensity and frequency of them is substantially reduced for the majority of people on treatment.

The MHRA approved a higher 7.2mg maintenance dose in January 2026, with a dedicated single-dose pen approved on 14 April 2026. Early trial data at that dose reported average weight loss of around 20.7% over 72 weeks, suggesting a stronger appetite effect too, though titration to 7.2mg follows the same gradual approach. Whether that dose is appropriate is a prescriber decision based on your full clinical picture.

It's also worth knowing that appetite response isn't uniform throughout treatment. Some people notice it dip slightly in the days before their next weekly injection, this is sometimes called the 'end of week' effect and tends to be more noticeable at lower doses. At maintenance, most people find the week-to-week variation smooths out considerably.

For a fuller look at how the medicine works across the whole treatment arc, the Wegovy overview page covers mechanism, schedule and what to discuss with a prescriber. If you're weighing up treatment options more broadly, the weight-loss treatment overview sets out what's currently licensed in the UK.

When appetite returns: what happens if you stop

This is a question worth answering honestly. For most people, appetite gradually returns after stopping Wegovy, the GLP-1 effect on hunger dissipates as semaglutide clears the body over several weeks. NHS England's weight-management guidance is clear that these medicines work alongside lifestyle changes, not instead of them; the habits built during treatment are what determine long-term outcomes.

NICE's recommendation for Wegovy (under TA875) specifies a maximum treatment duration of two years within a specialist service, which reflects this reality. Individual prescribers on private routes like ours review each patient's situation at every repeat, no automatic renewals, every prescription re-examined. If you're thinking about what happens beyond a course of treatment, our page on how long after stopping Wegovy appetite returns covers that in detail. And if the cost side of things is part of your thinking, our Wegovy treatment page explains what's included in a private prescription through us.

If you'd like a prescriber to assess whether Wegovy is right for you and talk through your expected timeline, you're welcome to speak to our prescribers, the consultation is free, and our clinical team reviews every application the same day it's submitted.